SCHEMBL29658149

SCHEMBL29658149

C[C@@H](O)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.61
OPRD1 P41143 2/20 0.61
KISS1R Q969F8 3/20 0.52
GHSR Q92847 3/20 0.51
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
PRMT1 Q99873 1/20 0.49
NMBR P28336 2/20 0.49
ACE P12821 1/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48
MPO P05164 1/20 0.48
MAPT P10636 1/20 0.48
TSHR P16473 1/20 0.48
BLM P54132 1/20 0.48
PMP22 Q01453 1/20 0.48
KMT2A Q03164 1/20 0.48
HIF1A Q16665 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30051166 0.92 OPRM1 (0.64) OPRM1OPRD1GHSRNMBRKDM4E
SCHEMBL29842333 0.91 KDM4E (0.56) OPRM1OPRD1PRMT1ACEKDM4E
SCHEMBL29551274 0.90 GHSR (0.60) KISS1RGHSRIL23R
SCHEMBL30169323 0.90 OPRM1 (0.62) OPRM1OPRD1GHSRKDM4EMEN1
SCHEMBL30834731 0.88 ACE (0.53) OPRM1OPRD1MMP2MMP9MMP8
SCHEMBL29564909 0.88 OPRM1 (0.63) OPRM1OPRD1GHSR
SCHEMBL30051966 0.88 OPRM1 (0.65) OPRM1OPRD1NMBR
SCHEMBL30665628 0.88 KISS1R (0.55) OPRM1OPRD1KISS1RGHSRPRMT1
SCHEMBL30052868 0.87 KDM4E (0.60) OPRM1OPRD1MMP2MMP9MMP8
SCHEMBL30123108 0.86 OPRD1 (0.54) OPRM1OPRD1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114478789-A anti-PD-L1 and OX40 bispecific antibodies and uses thereof 安徽安科生物工程(集团)股份有限公司 2022-05-13 CN disclosed